India: Back to the 20th Century?

Price controls are work of bad economists, politicians

  • by:
  • 03/02/2023
ad-image

Just when you think India has taken an economic step forward into the 21st century, it stands up and asserts its right to take two steps back.

Over the past few years, India has moved to strengthen intellectual property rights and abandon its legacy of counterfeiting and piracy. That's important because the country has a strong entertainment industry - "Bollywood" produces more films than Hollywood - as well as one of the largest pharmaceutical industries in the developing world.

And yet ... the government agency that oversees pharmaceuticals has proposed placing 354 "essential drugs" - medicines such as antibiotics that are considered fundamental to providing basic health care - under the Drugs Price Control Order (DPCO), in addition to the 74 drugs that are already price controlled.

Moreover, the government agency wants to limit the drug companies' "maximum allowable post-manufacturing expens" (MAPE) to 150% of production costs. Imposing price controls is a disincentive for pharmaceutical research and development and limits the growth of intellectual property.

Does the agency think that price controls are needed to ensure drugs are affordable for low-income populations?

Remember, the reason that some people claimed developing countries were justified in ignoring patents and buying from India was because the drugs there are high quality and low cost. That's in part because generic competition is rampant in India, and the cost of living is very low.

Indeed, observers have pointed out that the market price of some generics in India - only a few patented drugs are on the essential-medicines list - is actually lower than the controlled price.

As of this writing it appears that the Indian government is willing to put most of the medications under the DPCO. That's a huge mistake. Most of Europe imposed price controls on drugs years ago and then sat back and watched most of their pharmaceutical industry move to the U.S. India is a world leader in producing generic medicines and aims to be a leader in new drug development.

Price controls are what poor countries with bad economists and worse politicians do. Emerging economies with political visionaries turn to free markets. Which one will India be?

For more TechBytes go to ipi.org.

Image:

Opinion

View All

Elon Musk sues Brussels over €120 MILLION fine under EU anti-free speech Digital Services Act

In a post on Friday, X’s Global Government Affairs team said it filed an appeal with the General Cour...

CHAOS in Mexico after cartel head killed, tourist destinations hit with violence, US Embassy issues security alert

Nemesio Oseguera Cervantes, the Mexican drug lord commonly known as “El Mencho” and leader of the Jal...

Thousands of French citizens take to the streets to protest Antifa killing of nationalist Quentin Deranque

Thousands were seen marching in the streets of Lyon, France, declaring that there needs to be "justic...

Trump officials urge British free speech victims to seek asylum in US

"Anyone persecuted by their government for peacefully expressing their views, including British citiz...